Shah Wealth Advisors LLC Takes $819,000 Position in Cigna Group $CI

Shah Wealth Advisors LLC purchased a new stake in Cigna Group (NYSE:CI) in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 2,972 shares of the health services provider’s stock, valued at approximately $819,000.

Several other institutional investors have also recently bought and sold shares of the stock. Wilkerson Advisory Group LLC bought a new stake in shares of Cigna Group during the fourth quarter worth $25,000. Osbon Capital Management LLC bought a new position in Cigna Group in the second quarter valued at about $26,000. Johnson Financial Group Inc. acquired a new stake in Cigna Group in the second quarter worth about $29,000. Kemnay Advisory Services Inc. acquired a new stake in Cigna Group in the fourth quarter worth about $29,000. Finally, Prosperity Bancshares Inc bought a new stake in Cigna Group during the 4th quarter worth about $29,000. Institutional investors own 86.99% of the company’s stock.

Insider Transactions at Cigna Group

In other Cigna Group news, insider Nicole Jones sold 19,436 shares of the stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total value of $5,369,583.72. Following the completion of the sale, the insider directly owned 27,256 shares in the company, valued at $7,530,015.12. This represents a 41.63% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie Kates sold 899 shares of the firm’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the sale, the chief accounting officer directly owned 2,368 shares in the company, valued at approximately $707,108.48. This represents a 27.52% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 23,012 shares of company stock valued at $6,386,550. Insiders own 0.60% of the company’s stock.

Cigna Group Stock Down 1.4%

Shares of NYSE:CI opened at $282.24 on Friday. The company has a 50 day moving average price of $283.51 and a two-hundred day moving average price of $281.07. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. The company has a market capitalization of $74.58 billion, a PE ratio of 11.68, a PEG ratio of 0.98 and a beta of 0.31. Cigna Group has a 52 week low of $239.51 and a 52 week high of $315.47.

Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, topping analysts’ consensus estimates of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The company had revenue of $70.04 billion for the quarter, compared to analysts’ expectations of $70.14 billion. During the same period last year, the firm posted $7.20 earnings per share. The business’s quarterly revenue was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Analysts forecast that Cigna Group will post 30.51 earnings per share for the current year.

Cigna Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be paid a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date of this dividend is Tuesday, September 8th. Cigna Group’s payout ratio is presently 25.82%.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on CI. Robert W. Baird set a $362.00 target price on shares of Cigna Group in a research note on Friday, July 31st. Barclays increased their price objective on shares of Cigna Group from $304.00 to $310.00 and gave the company an “equal weight” rating in a report on Friday, July 31st. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cigna Group in a research note on Thursday, August 27th. UBS Group lifted their target price on shares of Cigna Group from $375.00 to $400.00 and gave the stock a “buy” rating in a report on Friday, May 22nd. Finally, Jefferies Financial Group downgraded Cigna Group from a “buy” rating to a “hold” rating and cut their price target for the company from $336.00 to $307.00 in a research note on Tuesday, August 4th. Fifteen research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. Based on data from MarketBeat, Cigna Group has an average rating of “Moderate Buy” and a consensus price target of $339.45.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.